In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Anavex Life Sciences Corporation (NASDAQ: AVXL) closed at $9.4 down -1.36% from its previous closing price of $9.53. In other words, the price has decreased by -$1.36 from its previous closing price. On the day, 0.66 million shares were traded. AVXL stock price reached its highest trading level at $9.7199 during the session, while it also had its lowest trading level at $9.305.
Ratios:
For a deeper understanding of Anavex Life Sciences Corporation’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.93 and its Current Ratio is at 8.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40. On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 807401664 and an Enterprise Value of 717404224.
Stock Price History:
The Beta on a monthly basis for AVXL is 0.83, which has changed by 0.5460526 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, AVXL has reached a high of $14.44, while it has fallen to a 52-week low of $4.93. The 50-Day Moving Average of the stock is -9.95%, while the 200-Day Moving Average is calculated to be 0.60%.
Shares Statistics:
For the past three months, AVXL has traded an average of 1.01M shares per day and 940080 over the past ten days. A total of 85.41M shares are outstanding, with a floating share count of 83.02M. Insiders hold about 3.35% of the company’s shares, while institutions hold 38.04% stake in the company. Shares short for AVXL as of 1753920000 were 24810859 with a Short Ratio of 24.56, compared to 1751241600 on 25122132. Therefore, it implies a Short% of Shares Outstanding of 24810859 and a Short% of Float of 30.03.
Earnings Estimates
The current rating of Anavex Life Sciences Corporation (AVXL) is the result of assessments by 2.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.56 and -$0.58 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is $2.37, with 2.0 analysts recommending between $5.23 and -$0.49.
